<--- Back to Details
First PageDocument Content
Selective serotonin reuptake inhibitors / Bipolar disorder / Eli Lilly and Company / Amines / Nitriles / Paroxetine / Fluoxetine / Duloxetine / Antidepressant / Chemistry / Organic chemistry / Organofluorides
Selective serotonin reuptake inhibitors
Bipolar disorder
Eli Lilly and Company
Amines
Nitriles
Paroxetine
Fluoxetine
Duloxetine
Antidepressant
Chemistry
Organic chemistry
Organofluorides

ORIGINAL ARTICLE Association Between Treatment-Emergent Suicidal Ideation With Citalopram and Polymorphisms Near Cyclic Adenosine Monophosphate Response Element Binding Protein in the STAR*D Study

Add to Reading List

Source URL: archpsyc.jamanetwork.com

Download Document from Source Website

File Size: 164,85 KB

Share Document on Facebook

Similar Documents

Research Protocol for REAP Bipolar Disorder (REAP-BD) Summary REAP-BD survey will focus on the prescription patterns on bipolar disorder. Both inpatients and outpatients with bipolar disorder will be enrolled. Data in th

Research Protocol for REAP Bipolar Disorder (REAP-BD) Summary REAP-BD survey will focus on the prescription patterns on bipolar disorder. Both inpatients and outpatients with bipolar disorder will be enrolled. Data in th

DocID: 1uRe0 - View Document

What you need to know about  Bipolar Disorder What is it? Bipolar disorder is in a class of mood disorders that is marked by dramatic changes in mood, energy and

What you need to know about Bipolar Disorder What is it? Bipolar disorder is in a class of mood disorders that is marked by dramatic changes in mood, energy and

DocID: 1u22A - View Document

Patient information from BMJ Last published: Dec 01, 2016 Bipolar disorder: what is it? Most of us have ups and downs in our moods. But if you have bipolar disorder, your mood swings are much more extreme and disrupt you

Patient information from BMJ Last published: Dec 01, 2016 Bipolar disorder: what is it? Most of us have ups and downs in our moods. But if you have bipolar disorder, your mood swings are much more extreme and disrupt you

DocID: 1sX7O - View Document

The use of triiodothyronine as an augmentation agent in treatment-resistant bipolar II and bipolar disorder NOS

The use of triiodothyronine as an augmentation agent in treatment-resistant bipolar II and bipolar disorder NOS

DocID: 1sHB2 - View Document

Health Net Behavioral Health Benefit Plan

Health Net Behavioral Health Benefit Plan

DocID: 1rmb0 - View Document